2010;67(13):1061-1069. Considering all of the data and their limitations, questions still remain regarding the optimal treatment of COPD exacerbations. The data of deJong et al. [30] showed no ...

Compared with DPP-4 inhibitors, SGLT2 inhibitors and GLP-1RAs conferred lower risks for COPD exacerbation among patients with type 2 diabetes. Among patients with type 2 diabetes (T2D) and active ...

In acute infective exacerbation of chronic bronchitis or chronic obstructive pulmonary disease (COPD), adding erdosteine to standard treatment significantly modified the outcome by improving the ...

Background The COPD Best Practice Tariff (BPT) is a pay-for-performance scheme in England that incentivises review by a respiratory specialist within 24 hours of admission and completion of a list of ...

Background The natural history and time course of the onset of exacerbation events of chronic obstructive pulmonary disease (COPD) is incompletely understood. Methods A prospective cohort of 212 ...

Background: Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) significantly impacts patient quality of life and prognosis. Skeletal muscle mass loss, a systemic manifestation of ...

A new study published in the journal of BMC Pulmonary Medicine showed that dyspnea (mMRC score 1.67), symptom load (CAT score ...

Endpoints were the efficacy of dupilumab in the intention-to-treat population, including annualized rate of moderate or severe acute COPD exacerbations during the 52-week treatment period, and change ...

Background In 2009 the Wellington Free Ambulance implemented an education programme to reduce high concentration oxygen delivery to patients with an acute exacerbation of chronic obstructive pulmonary ...

5 Between 30–50% of people with COPD are at increased cardiopulmonary risk. However, identification and management of this risk is currently suboptimal due to a lack of familiarity with the concept. 5 ...